<?xml version="1.0" encoding="UTF-8"?>
<ref id="cit0057">
 <label>57.</label>
 <mixed-citation publication-type="journal">
  <string-name>
   <surname>Cascella</surname>
   <given-names>M</given-names>
  </string-name>, 
  <string-name>
   <surname>Bimonte</surname>
   <given-names>S</given-names>
  </string-name>, 
  <string-name>
   <surname>Muzio</surname>
   <given-names>MR</given-names>
  </string-name>, 
  <string-name>
   <surname>Schiavone</surname>
   <given-names>V</given-names>
  </string-name>, 
  <string-name>
   <surname>Cuomo</surname>
   <given-names>A</given-names>
  </string-name>. 
  <article-title>The efficacy of epigallocatechin-3-gallate (green tea) in the treatment of alzheimer’s disease: an overview of pre-clinical studies and translational perspectives in clinical practice</article-title>. 
  <source>
   <italic toggle="yes">Infect Agent Cancer</italic>
  </source>. 
  <year>2017</year>;
  <volume>12</volume>(
  <issue>1</issue>):
  <fpage>1</fpage>–
  <lpage>7</lpage>. doi:
  <pub-id pub-id-type="doi">10.1186/s13027-017-0145-6</pub-id>
  <pub-id pub-id-type="pmid">28053656</pub-id>
 </mixed-citation>
</ref>
